Belgium: Corporate and Company Law

Belgium's new Private Investigations Act fundamentally transforms how companies must conduct internal investigations, establishing comprehensive legal requirements for everything from fraud inquiries to HR incidents.

Addressing antimicrobial resistance (AMR) is one of the key objectives of the EU’s legislative reform. However, the development pipeline for new effective antimicrobials is obstructed, primarily due to a profound market failure: the low commercial value of the antimicrobial medicinal product market (costly development versus naturally limited market). In short, the market alone cannot deliver the solutions urgently needed to address AMR.

According to the Commission, the package is in response to increased calls from EU businesses to reduce the regulatory burden of sustainability legislation passed under the EU Green Deal.